Vigonvita Life Sciences Co., Ltd. (HKG:2630)
75.20
+2.35 (3.23%)
Nov 17, 2026, 4:08 PM HKT
Vigonvita Life Sciences Revenue
Vigonvita Life Sciences had revenue of 65.89M CNY in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 217.26M. In the year 2025, Vigonvita Life Sciences had annual revenue of 102.10M with 762.88% growth. That makes Vigonvita Life Sciences the 30,985th largest company in the world by revenue and 1,857th in Hong Kong.
Revenue (ttm)
217.26M CNY
Revenue Growth
+762.88%
P/S Ratio
49.81
Revenue / Employee
618.98K CNY
Employees
351
Market Cap
12.60B HKD
Revenue by Geography
- People's Republic of China (PRC) 101.94M 99.8%
- Uzbekistan 156.00K 0.2%
Fiscal year ended Dec 31, 2025 See the full Vigonvita Life Sciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.10M | 90.26M | 762.88% |
| Dec 31, 2024 | 11.83M | -187.82M | -94.07% |
| Dec 31, 2023 | 199.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Vigonvita Life Sciences News
- 2 months ago - Vigonvita Life Sciences Earnings release: H1 2026 - Filings
- 2 months ago - Vigonvita Life Sciences Quarterly report: H1 2026 - Filings